Quantification of drugs of abuse and related substances in biological specimens. Period of performance: june 14, 2024 - june 13, 2025.
Active Definitive Contract Awarded Last action
- Contract number
- 75N95024C00014
- Awardee
-
University Of Utah UEI LL8GLEVH6MG3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $782,637
Award facts
- Opportunity
-
- Quantification of Drugs of Abuse and Related Substances in Biological Specimens Pre-Solicitation · 75N95024R00006 · Posted Aug 18, 2023
- Contract value 33% obligated
-
- $782,636.68 Current, with exercised options
- $2,338,198.48 Potential, with all options
- Completion date 48% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Salt Lake City, UT 84112, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $236,188 | |
| Change Order | $230,116 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $316,333 |
About this award
The National Institute on Drug Abuse awarded a definitive contract to University of Utah for quantification of drugs of abuse and related substances in biological specimens on June 14, 2024, with a ceiling value of $2,338,198.48.
The contract covers analysis of experimental samples for drug concentrations in biological fluids and tissues, development of specific and sensitive methods for existing and novel compounds, and development of assays requiring specialized analytical capability. The contractor must possess DEA Registration for Chemical Analysis or DEA Research Registration for Schedules II through V controlled substances, with capability to obtain Schedule I registration, and maintain secured facilities for biological sample and data storage with computerized tracking systems from sample receipt through final data report. Place of performance is Salt Lake City, UT.
The base period runs through June 13, 2025, with options extending to June 13, 2027, and ultimate completion date of June 13, 2029. The contract is priced on a cost-plus-fixed-fee basis with no small business set-aside.
Service Contract Inventory data shows FY2024 invoiced revenue of $62 thousand across 1,168 contractor hours (0.6 FTEs) at a derived rate of $53.09 per hour, with FY2025 invoiced revenue of $279 thousand at 0.9 FTEs. University of Utah self-performed all reported hours with no subcontractor engagement.
Quick answers
Who was awarded contract 75N95024C00014?
75N95024C00014 was awarded to University Of Utah by National Institute on Drug Abuse (National Institutes of Health) on June 14, 2024.
How much is contract 75N95024C00014 worth?
The government has obligated $782,637 on 75N95024C00014. Its potential value, with all options, is $2,338,198.
Was contract 75N95024C00014 competed?
The extent of competition for 75N95024C00014 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award